Anavex refreshes board and urges rejection of PVG proxy fight
Anavex Life Sciences nominated two new independent directors and filed a preliminary proxy statement to reject takeover attempts by PVG Asset Management and Patrick Adams while establishing an Executive Committee led by Dr. Jiong Ma.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day